Lesinurad and Allopurinol Combination Extension Study in Gout

Study identifier:RDEA594-306

ClinicalTrials.gov identifier:NCT01808131

EudraCT identifier:2012-004389-16

CTIS identifier:N/A

Study Complete

Official Title

A Long-Term Extension Study of Lesinurad in Combination with Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol

Medical condition

Gout

Phase

Phase 3

Healthy volunteers

No

Study drug

Lesinurad

Sex

All

Actual Enrollment

717

Study type

Interventional

Age

18 Years - 85 Years

Date

Study Start Date: 01 Feb 2013
Primary Completion Date: 01 Aug 2016
Study Completion Date: 01 Nov 2016

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Jan 2017 by Ardea Biosciences, Inc.

Sponsors

Ardea Biosciences, Inc.

Collaborators

-

Inclusion and exclusion criteria